Recital 239, Decision_act (EU) 2002/742

In forcesince 5 Dec 2001

On the basis of the foregoing, the appropriate starting amount for a fine, on the basis of the criterion of relative importance in the market concerned, is as follows:

–

Haarmann & Reimer: EUR 35 million,

–

ADM, Hoffmann-La Roche and Jungbunzlauer: EUR 21 million,

–

Cerestar Bioproducts: EUR 3,5 million.

Sufficient deterrence